CD4 and HIV infectious disease: However, there are several unique challenges when targeting engineered T cells at HIV including minute levels of antigen after infusion of T cells into PLWH controlling HIV using ART, the susceptibility of T cells to HIV infection, loss of CD4 T cell helper functions, and the rate and mechanism by which HIV can spread [46].